Scarica l'app Stockscreener
7.36
3.08%
0.22
Dopo l'orario di chiusura:
7.36
Precedente Chiudi:
$7.14
Aprire:
$7.12
Volume 24 ore:
381.01K
Relative Volume:
1.19
Capitalizzazione di mercato:
$347.65M
Reddito:
$561.30K
Utile/perdita netta:
$-88.91M
Rapporto P/E:
-3.9099
EPS:
-1.8824
Flusso di cassa netto:
$-62.47M
1 W Prestazione:
+3.52%
1M Prestazione:
+26.90%
6M Prestazione:
+14.11%
1 anno Prestazione:
+96.27%
Intervallo 1D:
$6.978
$7.42
Intervallo di 1 settimana:
$6.84
$7.50
Portata 52W:
$3.535
$8.40
Silence Therapeutics Plc Adr Stock (SLN) Company Profile
Nome
Silence Therapeutics Plc Adr
Settore
Industria
Telefono
44-0-20-3457 6900
Indirizzo
12 HAMMERSMITH GROVE, LONDON
Compare SLN vs VRTX, REGN, ARGX, ALNY, ONC
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
SLN
Silence Therapeutics Plc Adr
|
7.36 | 337.26M | 561.30K | -88.91M | -62.47M | -1.8824 |
VRTX
Vertex Pharmaceuticals Inc
|
427.65 | 107.87B | 12.32B | 4.34B | 3.19B | 16.86 |
REGN
Regeneron Pharmaceuticals Inc
|
721.05 | 73.63B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
807.55 | 49.42B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
303.00 | 40.20B | 3.71B | 313.75M | 465.38M | 2.2571 |
ONC
Beone Medicines Ltd Adr
|
313.32 | 33.06B | 5.36B | 287.73M | 924.18M | 2.5229 |
Silence Therapeutics Plc Adr Stock (SLN) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-02-11 | Iniziato | Goldman | Sell |
| 2024-12-02 | Reiterato | BMO Capital Markets | Outperform |
| 2024-09-03 | Iniziato | Jefferies | Buy |
| 2024-01-31 | Iniziato | BMO Capital Markets | Outperform |
Silence Therapeutics Plc Adr Borsa (SLN) Ultime notizie
Revenue per share of Silence Therapeutics PLC Sponsored ADR – DUS:XRP2 - TradingView
Book value per share of Silence Therapeutics PLC Sponsored ADR – DUS:XRP2 - TradingView
Silence Therapeutics (SLN) soars 19.0%: Is further upside left in the stock? - MSN
Silence Therapeutics PLC Sponsored ADR (NASDAQ:SLN) Short Interest Up 13.3% in April - MarketBeat
Silence Therapeutics PLC Sponsored ADR (NASDAQ:SLN) Given Average Rating of "Moderate Buy" by Brokerages - MarketBeat
Silence Therapeutics (NASDAQ:SLN) Shares Down 1.8%Here's What Happened - MarketBeat
Wall Street Analysts Think Silence Therapeutics (SLN) Could Surge 556.19%: Read This Before Placing a Bet - MSN
Polycythemia Vera Market Set for Transformation: Key 9 Companies Expected to Enter by 2036 | DelveInsight - GlobeNewswire Inc.
Silence Therapeutics (SLN) Soars 19.0%: Is Further Upside Left in the Stock? - Yahoo Finance
Silence Therapeutics PLC Sponsored ADR (NASDAQ:SLN) Given Average Recommendation of "Moderate Buy" by Brokerages - marketbeat.com
Silence Therapeutics PLC Sponsored ADR (NASDAQ:SLN) Given Average Recommendation of “Moderate Buy” by Brokerages - Defense World
Why Urgent.ly Shares Are Trading Higher By Around 159%; Here Are 20 Stocks Moving Premarket - Benzinga
What is HC Wainwright's Estimate for SLN FY2030 Earnings? - MarketBeat
What is HC Wainwright’s Estimate for SLN FY2030 Earnings? - Defense World
Silence Therapeutics PLC Sponsored ADR (NASDAQ:SLN) Receives Consensus Recommendation of "Hold" from Analysts - MarketBeat
Silence Therapeutics Q4 Earnings Assessment - Sahm
Wall Street Analysts See a 467.47% Upside in Silence Therapeutics (SLN): Can the Stock Really Move This High? - Yahoo Finance
Wall Street experts predict a potential 467.47% increase for Silence Therapeutics (SLN): Is such a surge in the stock truly possible? - Bitget
Analysts Set Silence Therapeutics PLC Sponsored ADR (NASDAQ:SLN) Price Target at $32.60 - Defense World
Silence Therapeutics PLC Sponsored ADR (NASDAQ:SLN) Receives Consensus Rating of "Hold" from Analysts - MarketBeat
Silence Therapeutics (NASDAQ:SLN) Shares Down 5.1%Here's What Happened - MarketBeat
Revenues Working Against Silence Therapeutics plc's (NASDAQ:SLN) Share Price Following 27% Dive - Sahm
Here's Why We're Watching Silence Therapeutics' (NASDAQ:SLN) Cash Burn Situation - Sahm
Silence Therapeutics ADR share price | SLN - Hargreaves Lansdown
H.C. Wainwright reiterates Buy rating on Silence Therapeutics stock at $75 By Investing.com - Investing.com India
H.C. Wainwright reiterates Buy rating on Silence Therapeutics stock at $75 - Investing.com
Silence Therapeutics PLC Sponsored ADR (NASDAQ:SLN) Receives Consensus Recommendation of "Hold" from Brokerages - MarketBeat
Silence Therapeutics (NASDAQ:SLN) Trading Down 0.7%Should You Sell? - MarketBeat
Silence Therapeutics (NASDAQ:SLN) Trading Down 0.7% – Should You Sell? - Defense World
Silence Therapeutics Insider Ups Holding During Year - Sahm
Comparing PMV Pharmaceuticals (NASDAQ:PMVP) & Silence Therapeutics (NASDAQ:SLN) - Defense World
Was Autonomix Medical Inc (AMIX)’s session last reading good? - uspostnews.com
Wall Street Analysts Believe Silence Therapeutics (SLN) Could Rally 590.66%: Here's is How to Trade - MSN
Silence Therapeutics PLC Sponsored ADR (NASDAQ:SLN) Receives Average Recommendation of “Hold” from Analysts - Defense World
Silence Therapeutics PLC Sponsored ADR (NASDAQ:SLN) Receives Average Recommendation of "Hold" from Analysts - MarketBeat
Silence Therapeutics appoints CFO Rhonda Hellums to board of directors By Investing.com - Investing.com South Africa
Silence Therapeutics appoints CFO Rhonda Hellums to board of directors - Investing.com
Silence Therapeutics CEO Craig Tooman steps down By Investing.com - Investing.com India
Silence Therapeutics CEO Craig Tooman steps down - Investing.com
Silence Therapeutics Plc Adr Azioni (SLN) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.77%
0.25%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):